Is there a correlation between increasing olaparib dosage and a spike in CA-125 tumor marker levels?
Based on available information, there isn't a documented direct correlation between olaparib dosage increases and CA-125 level spikes. Olaparib is a maintenance therapy used to prevent cancer recurrence, and its effectiveness Show Full Answer
Is there a correlation between increasing olaparib dosage and a spike in CA-125 tumor marker levels?
Based on available information, there isn't a documented direct correlation between olaparib dosage increases and CA-125 level spikes. Olaparib is a maintenance therapy used to prevent cancer recurrence, and its effectiveness is typically monitored through CA-125 levels over time.
CA-125 levels are used to track treatment response. Generally:
- Decreasing CA-125 suggests the cancer is responding to treatment
- Increasing or plateauing CA-125 may indicate lack of treatment response or potential cancer recurrence
If you're experiencing a CA-125 spike while on olaparib, this could indicate that the cancer is progressing despite treatment rather than being caused by the medication itself. It's important to discuss any changes in your CA-125 levels with your oncologist, as they may need to adjust your treatment approach.
The most common side effects of olaparib relate to blood cell counts (particularly anemia), which is why regular blood monitoring is recommended during treatment.
November 26, 2025
Join
Your Privacy Choices
